Edit

About Us

Li Med one of the fastest growing Pharmaceutical Companies in India, was promoted by a group of young and experienced professionals and businessmen with the aim of providing International quality pharmaceutical products at very competitive and affordable pricing and also with the commitment to maintain highest standards and by adhering to the norms set by the Government of India. With the backing of strong brand management and a vision for scalability, Li Med Labs is poised to emerge as the Leader in the Indian pharma segment with the active support of its team of highly proficient industry professionals and also by partnering with established C&Fs and Stockists across India. We take pride in recording successful and consistent management of new product launches and exploring new territories across India..

Get in Touch

Contact Info

C MONT LC Kid

It is a combination of medicine that contains Levocetirizine which is a class of antihistamine and Montelukast which is a class of leukotriene receptor antagonists. It is used to treat allergic symptoms like runny nose, watery eyes, sneezing, itching, hives, etc. C MONT LC tablet and syrup can be taken with or without food.

Description

Levocetirizine blocks the action of histamine, a chemical substance produced by the body which causes allergic symptoms.
Montelukast reduces leukotrienes, a chemical substance that causes swelling.
C MONT LC Kid syrup & Tablet is indicated in following conditions.
Indicated for the relief of symptoms associated with allergic rhinitis (seasonal and perennial) in adults and children 6 years of age and older.
Indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older.
Prophylaxis and chronic treatment of asthma in patients 12 months of age and older.
Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older.
Relief of symptoms of allergic rhinitis (AR): seasonal allergic rhinitis (SAR) in patients 2 years of age and older, and perennial allergic rhinitis (PAR) in patients 6 months of age and older.

Related products

HOME
CONTACT
PRODUCTS
Facebook Twitter Linkedin

© Li Med Labs